Contact
searchSearch
HMP Global

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Cutting Through Cost Barriers for Heart Failure Medications
03/02/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the latest installment of Talking Therapeutics, Dr Jennings provides a brief history of heart failure medications and discusses the cost effectiveness of quadruple, triple, and double therapy regimens.
In the latest installment of Talking Therapeutics, Dr Jennings provides a brief history of heart failure medications and discusses the cost effectiveness of quadruple, triple, and double therapy regimens.
In the latest installment of...
03/02/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
ACC Updates Part 2
06/01/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking...
06/01/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
ACC Updates Part 2
06/01/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking...
06/01/2021
Pharmacy Learning Network
Headshot of Mark Munger, PharmD
Commentary
An Update on Heart Failure: World-Wide Burden, Rural Versus Urban Adults, Ethnic Disparities, and Remote Monitoring
06/01/2021
Mark A. Munger, PharmD, FCCP, FACC, FHFSA
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides...
06/01/2021
Pharmacy Learning Network
Headshot of Mark Munger, PharmD
Commentary
An Update on Heart Failure: World-Wide Burden, Rural Versus Urban Adults, Ethnic Disparities, and Remote Monitoring
06/01/2021
Mark A. Munger, PharmD, FCCP, FACC, FHFSA
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides...
06/01/2021
Pharmacy Learning Network
Talking Therapeutics
Heart Failure Treatment Insight From ACC.2021
05/19/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of...
05/19/2021
Pharmacy Learning Network
Talking Therapeutics
Heart Failure Treatment Insight From ACC.2021
05/19/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of...
05/19/2021
Pharmacy Learning Network
Commentary
Hypertension, Hyperlipidemia for Developing and Sustaining Atrial Fibrillation
05/04/2021
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of...
05/04/2021
Pharmacy Learning Network
Commentary
Hypertension, Hyperlipidemia for Developing and Sustaining Atrial Fibrillation
05/04/2021
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of...
05/04/2021
Pharmacy Learning Network
Talking Therapeutics
V is for Victory in Heart Failure
04/28/2021
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
In this week’s issue of Talking...
04/28/2021
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use